These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 34494955)

  • 21. Impact of disease activity on impaired glucose metabolism in patients with rheumatoid arthritis.
    Ristić GG; Subota V; Stanisavljević D; Vojvodić D; Ristić AD; Glišić B; Petronijević M; Stefanović DZ
    Arthritis Res Ther; 2021 Mar; 23(1):95. PubMed ID: 33771189
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Multipathway In Vitro Pharmacological Characterization of Specialized Proresolving G Protein-Coupled Receptors.
    Merlin J; Park J; Vandekolk TH; Fabb SA; Allinne J; Summers RJ; Langmead CJ; Riddy DM
    Mol Pharmacol; 2022 Apr; 101(4):246-256. PubMed ID: 35125345
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Macrophage sub-populations and the lipoxin A4 receptor implicate active inflammation during equine tendon repair.
    Dakin SG; Werling D; Hibbert A; Abayasekara DR; Young NJ; Smith RK; Dudhia J
    PLoS One; 2012; 7(2):e32333. PubMed ID: 22384219
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Lack of resolution sensor drives age-related cardiometabolic and cardiorenal defects and impedes inflammation-resolution in heart failure.
    Tourki B; Kain V; Pullen AB; Norris PC; Patel N; Arora P; Leroy X; Serhan CN; Halade GV
    Mol Metab; 2020 Jan; 31():138-149. PubMed ID: 31918915
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The comparative responsiveness of the patient self-report questionnaires and composite disease indices for assessing rheumatoid arthritis activity in routine care.
    Salaffi F; Ciapetti A; Gasparini S; Carotti M; Bombardieri S;
    Clin Exp Rheumatol; 2012; 30(6):912-21. PubMed ID: 22935335
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The relationships of CD8+ T cell subsets in RA patients with disease activity and clinical parameters.
    He J; Li Y; Chen J; Wu Q; Shan H; Wang X; Zhang M; Nie L; Wang Q
    Int Immunopharmacol; 2023 Jan; 114():109399. PubMed ID: 36442285
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Lipoxin A
    Gaudin A; Tolar M; Peters OA
    Sci Rep; 2018 Jun; 8(1):8921. PubMed ID: 29892010
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Evaluation of disease activity indices in Korean patients with rheumatoid arthritis.
    Park SY; Lee H; Cho SK; Choi CB; Sung YK; Bae SC
    Rheumatol Int; 2012 Feb; 32(2):545-9. PubMed ID: 21305296
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Heterologously expressed formyl peptide receptor 2 (FPR2/ALX) does not respond to lipoxin A₄.
    Hanson J; Ferreirós N; Pirotte B; Geisslinger G; Offermanns S
    Biochem Pharmacol; 2013 Jun; 85(12):1795-802. PubMed ID: 23643932
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Lack of activity of 15-epi-lipoxin A₄ on FPR2/ALX and CysLT1 receptors in interleukin-8-driven human neutrophil function.
    Planagumà A; Domenech T; Jover I; Ramos I; Sentellas S; Malhotra R; Miralpeix M
    Clin Exp Immunol; 2013 Aug; 173(2):298-309. PubMed ID: 23607720
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Characterization of neutrophil-to-lymphocyte ratio as a measure of inflammation in rheumatoid arthritis.
    Chandrashekara S; Mukhtar Ahmad M; Renuka P; Anupama KR; Renuka K
    Int J Rheum Dis; 2017 Oct; 20(10):1457-1467. PubMed ID: 28952205
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Comparison of Disease Activity Score in 28 joints with ESR (DAS28), Clinical Disease Activity Index (CDAI), Health Assessment Questionnaire Disability Index (HAQ-DI) & Routine Assessment of Patient Index Data with 3 measures (RAPID3) for assessing disease activity in patients with rheumatoid arthritis at initial presentation.
    Kumar BS; Suneetha P; Mohan A; Kumar DP; Sarma KVS
    Indian J Med Res; 2017 Nov; 146(Supplement):S57-S62. PubMed ID: 29578196
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Serum calprotectin may reflect inflammatory activity in patients with active rheumatoid arthritis despite normal to low C-reactive protein.
    Hurnakova J; Hulejova H; Zavada J; Komarc M; Cerezo LA; Mann H; Vencovsky J; Pavelka K; Senolt L
    Clin Rheumatol; 2018 Aug; 37(8):2055-2062. PubMed ID: 29656372
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Rheumatoid Arthritis Patients With Circulating Extracellular Vesicles Positive for IgM Rheumatoid Factor Have Higher Disease Activity.
    Arntz OJ; Pieters BCH; Thurlings RM; Wenink MH; van Lent PLEM; Koenders MI; van den Hoogen FHJ; van der Kraan PM; van de Loo FAJ
    Front Immunol; 2018; 9():2388. PubMed ID: 30420853
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Correlation between serum CCL20 level and disease severity in patients with rheumatoid arthritis].
    Du LY; Zhang MJ; Liu PF; Xiao G; Lyu XM
    Zhonghua Yu Fang Yi Xue Za Zhi; 2021 Feb; 55(2):226-232. PubMed ID: 34645184
    [No Abstract]   [Full Text] [Related]  

  • 36. Are the C-reactive protein values and erythrocyte sedimentation rate equivalent when estimating the 28-joint disease activity score in rheumatoid arthritis?
    Castrejón I; Ortiz AM; García-Vicuña R; Lopez-Bote JP; Humbría A; Carmona L; Gonzalez-Alvaro I
    Clin Exp Rheumatol; 2008; 26(5):769-75. PubMed ID: 19032807
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effect of Sanhuangyilong decoction plus methotrexate on tumor necrosis factor alpha and interferon gamma in serum and synovial fluid in rheumatoid arthritis patients with symptom pattern of damp heat obstruction.
    Liu D; Yan J; Yun M; Yang M; Luo Y; Zhang J; Guo M; Yang M; Yuan W; Zou W; Li H; Hu Y
    J Tradit Chin Med; 2016 Oct; 36(5):625-33. PubMed ID: 29933531
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Epigenetic regulation of the formyl peptide receptor 2 gene.
    Simiele F; Recchiuti A; Patruno S; Plebani R; Pierdomenico AM; Codagnone M; Romano M
    Biochim Biophys Acta; 2016 Oct; 1859(10):1252-8. PubMed ID: 27424221
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Can Cytokines be used as an Activation Marker in Rheumatoid Arthritis?
    Kaya FÖ; Ceylan Y; İpek BÖ; Özünal ZG; Sezgin G; Nalbant S
    Endocr Metab Immune Disord Drug Targets; 2021; 21(8):1459-1465. PubMed ID: 33076814
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Remission in rheumatoid arthritis by different criteria does not converge over the inflammatory markers.
    Chandrashekara S; Priyanka BU
    Int J Rheum Dis; 2013 Jun; 16(3):291-6. PubMed ID: 23981750
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.